
- Home
- Products & Services
ProfitGuard
Group purchasing and wholesaler contract negotiation service with business intelligence tools.
BuyLineA no-contract online pharmaceutical ordering service with competitive pricing and loyalty rewards points.
- About
- Elements
- News
- Resources
- Contact
Teva Recalls Drugs With Probable Carcinogen
December 7, 2018
Teva Pharmaceuticals has recalled two drugs used to treat high blood pressure due to the presence of a probable human carcinogen, N-nitroso-diethylamine (NDEA).
The recall affects all lots of:
- Amlodipine / Valsartan combination tablets
- Amlodipine / Valsartan / Hydrochlorothiazide combination tablets
Pharmacies can contact Teva by phone at 888-838-2872, or email atĀ druginfo@tevapharm.com.
View the full list of recalled products in the FDA press release.
Related
Archive
- 2019
- February
- January
- 2018
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2017
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2016
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2015
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2014
- December
- November
- October
- September
- August
- March
- February
- 2013
- July
- June
- May
- April
- 2012
- December
- June
- April
- March
- February
- 2011
- December
- November
- August
- July
© 2019 PBA Health. All rights reserved.
MENU